Radiotherapy combination opportunities leveraging immunity for the next oncology practice

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Ca

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3322/caac.21358PMID 27570942
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses

  2016cited by this paper
• Pembrolizumab for the treatment of non-small cell lung cancer

  2016cited by this paper
• Oligometastases

  2016cited by this paper
• CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.

  2016cited by this paper
• Cancer Immunology: Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

  2016cited by this paper
• Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma.

  2016influential reference
• Neoantigens in cancer immunotherapy

  2015cited by this paper
• An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression

  2015cited by this paper
• Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine

  2015cited by this paper
• Pembrolizumab for the treatment of non-small-cell lung cancer.

  2015cited by this paper
• TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity.

  2015cited by this paper
• Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions

  2015cited by this paper
• Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

  2015cited by this paper
• Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer

  2015influential reference
• Pembrolizumab versus Ipilimumab in Advanced Melanoma.

  2015cited by this paper
• An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression

  2015cited by this paper
• Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients

  2015cited by this paper
• Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents.

  2015cited by this paper
• Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

  2015cited by this paper
• Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response.

  2015cited by this paper
• Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model

  2014cited by this paper
• Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing

  2014cited by this paper
• Is the “3+3” Dose-Escalation Phase I Clinical Trial Design Suitable for Therapeutic Cancer Vaccine Development? A Recommendation for Alternative Design

  2014cited by this paper
• STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.

  2014cited by this paper
• Abscopal effect of radiation therapy: Interplay between radiation dose and p53 status

  2014cited by this paper
• Radiotherapy-Induced Anti-Tumor Immunity Contributes to the Therapeutic Efficacy of Irradiation and Can Be Augmented by CTLA-4 Blockade in a Mouse Model

  2014cited by this paper
• The Human Agonistic CD40 Antibody ADC-1013 Eradicates Bladder Tumors and Generates T-cell–Dependent Tumor Immunity

  2014cited by this paper
• Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function

  2014cited by this paper
• Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen

  2014cited by this paper
• Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy

  2014cited by this paper
• Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death

  2014cited by this paper
• The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma

  2014cited by this paper
• Radio‐responsive tumors exhibit greater intratumoral immune activity than nonresponsive tumors

  2014cited by this paper
• Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.

  2014cited by this paper
• Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

  2014influential reference
• The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer

  2014cited by this paper
• Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab.

  2014cited by this paper
• Genetic basis for clinical response to CTLA-4 blockade in melanoma.

  2014cited by this paper
• Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial.

  2014cited by this paper
• Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes

  2014cited by this paper
• Radiation Therapy Induces an Adaptive Upregulation of PD-L1 on Tumor Cells Which May Limit the Efficacy of the Anti-Tumor Immune Response But Can Be Circumvented by Anti-PD-L1

  2014cited by this paper
• Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas.

  2013cited by this paper
• Mining Exomic Sequencing Data to Identify Mutated Antigens Recognized by Adoptively Transferred Tumor-reactive T cells

  2013cited by this paper
• TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy.

  2013cited by this paper
• Macrophage regulation of tumor responses to anticancer therapies.

  2013cited by this paper
• Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4

  2013cited by this paper
• Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling

  2013influential reference
• Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma.

  2013cited by this paper
• Deciphering and reversing tumor immune suppression.

  2013cited by this paper
• Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion

  2013cited by this paper
• Radiation-Induced Equilibrium Is a Balance between Tumor Cell Proliferation and T Cell–Mediated Killing

  2013cited by this paper
• Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy.

  2013cited by this paper
• In Situ Observation of the Effects of Local Irradiation on Cytotoxic and Regulatory T Lymphocytes in Cervical Cancer Tissue

  2013cited by this paper
• Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98.

  2013cited by this paper
• CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer.

  2013cited by this paper
• Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells

  2013cited by this paper
• Radiotherapy of Human Sarcoma Promotes an Intratumoral Immune Effector Signature

  2013cited by this paper
• An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non–Small Cell Lung Cancer

  2013cited by this paper
• Antitumor Effect of Paclitaxel Is Mediated by Inhibition of Myeloid-Derived Suppressor Cells and Chronic Inflammation in the Spontaneous Melanoma Model

  2013cited by this paper
• p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells

  2013cited by this paper
• Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

  2012cited by this paper
• Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death

  2012cited by this paper
• Survivin as a prognostic/predictive marker and molecular target in cancer therapy.

  2012cited by this paper
• Modulation of inflammatory immune reactions by low-dose ionizing radiation: molecular mechanisms and clinical application.

  2012cited by this paper
• Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.

  2012cited by this paper
• Image-guided radiotherapy: from current concept to future perspectives

  2012cited by this paper
• Maximizing tumor immunity with fractionated radiation.

  2012cited by this paper
• Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies.

  2012cited by this paper
• Local Delivery of lnterleukin-12 Using T Cells Targeting VEGF Receptor-2 Eradicates Multiple Vascularized Tumors in Mice

  2012cited by this paper
• Adoptive Transfer of Mammaglobin-A Epitope Specific CD8 T Cells Combined with a Single Low Dose of Total Body Irradiation Eradicates Breast Tumors

  2012cited by this paper
• Tumor immunotherapy directed at PD-1.

  2012cited by this paper
• Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma.

  2012cited by this paper
• Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

  2012cited by this paper
• Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses

  2012cited by this paper
• Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study

  2012cited by this paper
• An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy

  2012cited by this paper
• Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation

  2012cited by this paper
• Immunologic correlates of the abscopal effect in a patient with melanoma.

  2012cited by this paper
• Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study.

  2012cited by this paper
• A systemic complete response of metastatic melanoma to local radiation and immunotherapy.

  2012cited by this paper
• A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

  2012cited by this paper
• Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study.

  2012cited by this paper
• Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer

  2012cited by this paper
• Regulatory T Cells in γ Irradiation-Induced Immune Suppression

  2012cited by this paper
• Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.

  2012cited by this paper
• This information is current as Activation T Cells via Dendritic Cell + Effector CD 8 Radiotherapy Promotes Tumor-Specific

  2012cited by this paper
• Intestinal irradiation and fibrosis in a Th1-deficient environment.

  2012cited by this paper
• Low-Dose Fractionated Radiation Potentiates the Effects of Cisplatin Independent of the Hyper-Radiation Sensitivity in Human Lung Cancer Cells

  2011cited by this paper
• Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group.

  2011cited by this paper
• VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC

  2011cited by this paper
• The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity.

  2011cited by this paper
• TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo

  2011cited by this paper
• The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis

  2011cited by this paper
• CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans

  2011cited by this paper
• Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.

  2011cited by this paper
• Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells

  2011cited by this paper
• Different radiosensitivity of CD4+CD25+ regulatory T cells and effector T cells to low dose gamma irradiation in vitro

  2011cited by this paper
• CD91-dependent programming of T-helper cell responses following heat shock protein immunization.

  2011cited by this paper
• Polarization of tumor-associated macrophages: a novel strategy for vascular normalization and antitumor immunity.

  2011cited by this paper
• Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice

  2011cited by this paper

• Targeting Acod1/itaconate in Cancer Therapy: Mechanisms and Opportunities.

  2026cites this paper
• Modulating NOS2 of radiotherapy-recruited CCR2+ macrophages enhances radiosensitivity of hepatocellular carcinoma.

  2026cites this paper
• Irradiated Tumor Cell-Derived Microparticles Activate Systemic Anti-Tumor Immunity via the STING/NLRP3/GSDMD Axis in Neutrophils.

  2026cites this paper
• Radiotherapy for more efficacious novel anticancer drugs: a position paper from the European Society for Radiotherapy and Oncology (ESTRO) focus group on novel systemic therapies and radiotherapy.

  2026cites this paper
• Immune-Centered Cross-Talk Between Cancer Cells and the Tumor Microenvironment—Implications for Therapy

  2026cites this paper
• Consensus guidance of immune checkpoint inhibitors in locally advanced rectal cancer

  2026cites this paper
• A cochlea-sparing strategy for non-invasive control of intracranial schwannomas via peripheral irradiation and anti-PD-1 therapy enhanced by STING activation

  2026cites this paper
• Synergistic effects of radiotherapy and immunotherapy: improving oncological outcomes.

  2026cites this paper
• In situ self-assembled cell reservoir hydrogel for maneuvering multistage radioimmunotherapy

  2026cites this paper
• Case report: Short-course hypofractionated radiation therapy combined with immune checkpoint inhibitors for the treatment of advanced ovarian mucinous cystadenocarcinoma

  2025cites this paper
• Microneedle-adapted PAMAM-BSH delivery facilitates spatiotemporal matching for melanoma boron neutron capture therapy.

  2025cites this paper
• PD-1/PD-L1 Blockade Based Immunotherapy in Cancer Treatment

  2025cites this paper
• Microbiota-mediated modulation of radiosensitivity: mechanisms and therapeutic prospects of oral and gut microbiota, metabolites, and probiotics

  2025cites this paper
• Consolidative thoracic radiotherapy improves the prognosis of metastatic esophageal cancer in the chemoimmunotherapy era: a propensity score matching study

  2025cites this paper
• The Role of cGAS-STING in Remodeling the Tumor Immune Microenvironment Induced by Radiotherapy.

  2025cites this paper
• Atomically Precise Metal Nanoclusters for Bioimaging and Therapy: Progress and Perspectives

  2025cites this paper
• Immunogenic cell death inducers:Current advances and future perspectives

  2025cites this paper
• Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial.

  2025cites this paper
• Incidences of pneumonitis associated with the combination of radiotherapy and immune checkpoint inhibitors in lung cancer: a systematic review and meta-analysis

  2025cites this paper
• Chemoradioimmunotherapy versus chemoimmunotherapy or chemoradiotherapy in extensive‐stage small‐cell lung cancer: A retrospective analysis of survival outcomes

  2025cites this paper
• Radioligand Therapy in Metastatic Breast Cancer: Harnessing Precision Oncology.

  2025cites this paper
• Expert consensus on cancer treatment-related lung injury

  2025cites this paper
• Sequential surgery following Yttrium-90 resin microspheres combined with targeted therapy and immunotherapy for primary hepatocellular carcinoma: a case report

  2025cites this paper
• The clinical significance and potential therapeutic target of tumor-associated macrophage in non-small cell lung cancer

  2025cites this paper
• Radiation-induced upregulation of itaconate in macrophages promotes the radioresistance of non-small cell lung cancer by stabilizing NRF2 protein and suppressing immune response

  2025cites this paper
• Threading the Needle: Navigating Novel Immunotherapeutics in Pancreatic Ductal Adenocarcinoma

  2025cites this paper
• Biomaterial-based drug delivery systems for the therapy of malignant pleural effusion

  2025cites this paper
• Advances and Prospects of Stereotactic Radiosurgery and Stereotactic Ablative Body Radiotherapy: Evolving Paradigms in Precision Oncology

  2025cites this paper
• Plinabulin following radiation enhances dendritic cell maturation and checkpoint inhibitor retreatment of relapsed/refractory cancers.

  2025cites this paper
• CD274/PD-L1 copy number gained malignant peripheral nerve sheath tumor: A case report and literature review

  2025cites this paper
• Targeting SLC7A11 with sorafenib sensitizes stereotactic body radiotherapy in colorectal cancer liver metastasis.

  2025cites this paper
• Efficacy of metastasis-directed therapy in de novo metastatic nasopharyngeal carcinoma patients receiving chemo-immunotherapy and local regional radiotherapy: a multicenter retrospective study

  2025cites this paper
• Investigating the Protective Role of Quercus brantii Extract on HT29 Cell Viability Following Ionizing Radiation Exposure

  2025cites this paper
• Efficacy of adjuvant immunotherapy and immunochemotherapy in esophageal squamous cell carcinoma: A retrospective cohort study

  2025cites this paper
• Combining radiotherapy and immune checkpoint inhibitors in metastatic cancers: a 25-year review of safety outcomes by the ENRSO Group

  2025cites this paper
• LIMD2 is associated with an exhausted CD8⁺ T cell state linked to ICI response in clear cell renal cell carcinoma

  2025cites this paper
• Efficacy and safety of a novel treatment scheme of RC48-ADC plus PD-1 inhibitors in metastatic urothelial carcinoma: a multicenter real-world study

  2025influential citation
• FLASH Radiotherapy: From In Vivo Data to Clinical Translation.

  2025cites this paper
• Effect of chemoradiotherapy on the dynamics of circulating lymphocyte subsets in patients with non-metastatic nasopharyngeal carcinoma

  2025cites this paper
• Steroid-refractory Interstitial Lung Disease in Patients Receiving Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis

  2025cites this paper
• Targeting USP1 Potentiates Radiation‐Induced Type I IFN‐Dependent Antitumor Immunity by Enhancing Oligo‐Ubiquitinated SAR1A‐Mediated STING Trafficking and Activation

  2025cites this paper
• Intratumoral Injection of Cytotoxic Drugs Plus Hapten Elicits Significant Immune Responses in Sentinel Lymph Nodes

  2025cites this paper
• Facts and hopes in radioimmunotherapy of oligometastatic disease.

  2025cites this paper
• Revisiting Magna-Field Irradiation in the Current Era of Immunotherapy

  2025cites this paper
• Verteporfin‐Mediated In Situ Nanovaccine Based on Local Conventional‐Dose Hypofractionated Radiotherapy Enhances Antitumor and Immunomodulatory Effect

  2025cites this paper
• Stereotactic Body Radiation Therapy Alone or in Combination with Immunotherapy in Kidney Cancer: A Systematic Review.

  2025cites this paper
• Influence factor and mechanism of FLASH effect

  2025cites this paper
• Prospects and Challenges of Lung Cancer Vaccines

  2025cites this paper
• Microenvironmental regulation of solid tumour resistance to CAR T cell therapy

  2025cites this paper
• The radioresistance of clinically relevant radioresistant cell-derived tumors is determined by the cancer cells themselves, rather than by the surrounding stromal cells

  2025cites this paper
• Novel NLRP3 inhibitors mitigate acute radiation-induced lung injury by suppressing pyroptosis in alveolar epithelial cells.

  2025cites this paper
• Preoperative Radiotherapy-Induced Molecular and Immune Modulation in Early-Stage Breast Cancer: Results from the YOUNGSTER Trial.

  2025cites this paper
• A γ-ray responsive hydrogel “blasting fuse” for prevention of postoperative breast cancer recurrence and metastasis via radio-immunotherapy

  2025cites this paper
• Neoadjuvant camrelizumab combined with chemoradiotherapy and watch-and-wait strategy versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced oesophageal squamous cell carcinoma: study protocol of a randomised controlled trial (PALACE-3)

  2025cites this paper
• Preventive effects of low-dose radiation and hypofractionated radiation plus anti-programmed cell death protein 1 on lung metastasis in breast cancer

  2025cites this paper
• Establishment of whole tumor cell antigen-induced cellular immunotherapy for lung adenocarcinoma

  2025cites this paper
• Biomimetic Engineering of Hybrid Radiosensitizers to Boost Radiotherapy against Cancer Metastasis

  2025cites this paper
• Evolving role of radiation therapy in advanced/metastatic intrahepatic cholangiocarcinoma

  2025cites this paper
• Therapeutic application of nanosystems-based metalloptosis for enhanced tumor radiotherapy

  2025cites this paper
• Radiation Dose–Volume Effects on Negative Tumor-Draining Lymph Nodes Affected T-cell Activation and Prognosis in Esophageal Cancer with Chemoradiotherapy

  2025cites this paper
• Combinations of treatments based on radiotherapy or radionuclides to enhance immunotherapy efficacy in advanced prostate cancer: a systematic review

  2025cites this paper
• Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies

  2025cites this paper
• Pre-immunotherapy alters stereotactic ablative radiotherapy-induced systemic T cell responses in early-stage NSCLC

  2025cites this paper
• Impact of radiation therapy on the immunological tumor microenvironment.

  2025cites this paper
• Adjuvant Chemoradiation and Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer: A Randomized Clinical Trial.

  2025cites this paper
• Cascade reaction–driven biomimetic scintillant/metal–organic frameworks for X-ray triggered combinational therapy against glioma

  2025cites this paper
• PROCR diminishes the efficacy of radiation by impairing T-cell-mediated antitumour immunity

  2025cites this paper
• Immunotherapy combined with radiotherapy for advanced non-small cell lung cancer: Current status and challenge (Review)

  2025cites this paper
• A comparative study of postural fixation techniques for radiotherapy in upper abdominal malignancies

  2025cites this paper
• Efficacy of metastatic lesion radiotherapy in de novo metastatic nasopharyngeal carcinoma patients receiving local regional radiotherapy and chemo-immunotherapy: a multicenter retrospective study.

  2025cites this paper
• A case of remarkable response to combined radiation therapy, enfortumab vedotin, and pembrolizumab in metastatic urothelial carcinoma.

  2025cites this paper
• Computational insights into marine-derived pVHL-HIF1α inhibitors: pharmacophore modelling, molecular docking, MD simulations, MM/PBSA and DFT studies

  2025cites this paper
• Advancements in consolidative thoracic radiotherapy following first-line immunotherapy in conjunction with chemotherapy for extensive-stage small cell lung cancer

  2025cites this paper
• Pembrolizumab with external radiation therapy effectively controlled TMB-high unresectable recurrent parathyroid cancer: a case report with review of literature

  2024cites this paper
• Mechanism of immune activation mediated by genomic instability and its implication in radiotherapy combined with immune checkpoint inhibitors.

  2024cites this paper
• Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors

  2024cites this paper
• Durable Response to Atezolizumab in Extensive-Stage Small-Cell Lung Cancer Leading to 60 Months Overall Survival: A Case Report

  2024cites this paper
• Antibody targeting of anaerobic bacteria warms cold tumors and improves the abscopal effect of radiotherapy

  2024cites this paper
• PD-1/PD-L1 inhibitors for early and middle stage microsatellite high-instability and stable colorectal cancer: a review

  2024cites this paper
• Outcomes of definitive carbon-ion radiotherapy for cT1bN0M0 esophageal squamous cell carcinoma

  2024cites this paper
• Strategies for overcoming tumour resistance to immunotherapy: harnessing the power of radiation therapy

  2024cites this paper
• Feedback loop between hypoxia and energy metabolic reprogramming aggravates the radioresistance of cancer cells

  2024cites this paper
• A review and bibliometric analysis of global research on proton radiotherapy

  2024cites this paper
• Current views on mechanisms of the FLASH effect in cancer radiotherapy

  2024cites this paper
• Enhancing cancer immunotherapy: Exploring strategies to target the PD-1/PD-L1 axis and analyzing the associated patent, regulatory, and clinical trial landscape.

  2024cites this paper
• Sustained Secretion of CCL21 via an Implantable Cell Reservoir Hydrogel Enhances the Systemic Antitumor Effect of Radiotherapy.

  2024cites this paper
• Irradiated Tumour Cell-Derived Microparticles Upregulate MHC-I Expression in Cancer Cells via DNA Double-Strand Break Repair Pathway.

  2024cites this paper
• Combination low-dose cyclophosphamide with check-point blockade and ionizing radiation promote an abscopal effect in mouse models of melanoma.

  2024cites this paper
• Immunotherapy combined with cranial radiotherapy for driver-negative non-small-cell lung cancer brain metastases: a retrospective study.

  2024cites this paper
• Manipulating Radiation‐Sensitive Z‐DNA Conformation for Enhanced Radiotherapy

  2024cites this paper
• Treatment strategies and molecular mechanism of radiotherapy combined with immunotherapy in colorectal cancer.

  2024cites this paper
• Unraveling ETC complex I function in ferroptosis reveals a potential ferroptosis-inducing therapeutic strategy for LKB1-deficient cancers.

  2024cites this paper
• Targeting the Cascade Amplification of Macrophage Colony-stimulating Factor to Alleviate the Immunosuppressive Effects Following Radiotherapy

  2024cites this paper
• Glitches in the brain: the dangerous relationship between radiotherapy and brain fog

  2024cites this paper
• PD-1 inhibition combined with intensity-modulated radiotherapy, to better serve patients with retroperitoneal lymph node metastases from gastrointestinal cancer

  2024cites this paper
• A self‐assembled, genetically engineered, irradiated tumor cell debris vaccine

  2024cites this paper
• Beyond surgery: bladder preservation and the role of systemic treatment in localised muscle-invasive bladder cancer

  2024cites this paper
• Tumor-associated macrophages affect the treatment of lung cancer

  2024cites this paper
• Current Status and Progress of Systemic and Local Therapy for Intrahepatic Cholangiocarcinoma

  2024cites this paper
• Induction immunotherapy plus chemotherapy followed by definitive chemoradiation therapy in locally advanced esophageal squamous cell carcinoma: a propensity-score matched study

  2024cites this paper